EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of Serial Intralesional Steroid Injections on Risk of Recurrence in Idiopathic Subglottic Stenosis

Shengjie Ying iD, Peter Y F Zeng, Kevin Fung, Halema Khan, Matthew J Cecchini, Patrick MacInnis, Jennifer Anderson iD, Amir H Karimi, MohdWessam Al Jawhri, Harrison Pan, Nhi Le, Krista Joris und 6 weitere

The Laryngoscope · 2025

DOI: 10.1002/lary.32179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2025. Verfasst von Shengjie Ying und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, Western University, London, Ontario, Canada. Hauptthemen laut MEDLINE: Laryngostenosis, Glucocorticoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Laryngological Association, Academic Medical Organization of Southwestern Ontario, Department of Otolaryngology-Head and Neck Surgery at University of Toronto and Western University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Serial intralesional steroid injections (ILSIs) have been suggested to be an effective adjunct treatment for idiopathic subglottic stenosis (iSGS) by maintaining airway patency and extending inter‐surgical intervals. However, evidence for the effectiveness of serial ILSIs remains inconclusive. The current study aimed to assess whether ILSIs reduce the risk of subsequent surgical dilation (i.e., recurrence) in a cohort of patients with iSGS.

Methods

Prospectively collected clinical data for 75 female iSGS patients with 1–4 years of follow‐up were analyzed. To assess the effect of ILSI use on the risk of recurrence, we assessed both the time‐to‐first recurrence using a standard Cox proportional hazards model and all recurrences per patient using a recurrent‐events model. Overall, there were 36 patients who had received ILSIs at any point in the follow‐up period and 39 patients who had not.

Results

ILSI use was associated with a significantly reduced risk of recurrence in both time‐to‐first event (hazard ratio (HR) = 0.20, 95% confidence interval (CI) 0.08–0.49) and recurrent events (HR = 0.44, 95% CI 0.26–0.75) multivariate Cox proportional hazard models, along with older age at diagnosis and longer time since diagnosis (all p < 0.05). In the time‐to‐first event analysis, the median time to recurrence among those who had received ILSIs was 2.5 years compared to 1.4 years among those who had not. The number needed to treat with ILSIs to avoid one recurrence by 2 years follow‐up was two.

Conclusion

Serial ILSIs were associated with reduced risk of recurrence, along with older age at diagnosis and longer time since diagnosis. Level of Evidence 3 (non‐randomized controlled cohort/follow‐up study).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LaryngostenosisGlucocorticoidsHumansFemaleInjections, IntralesionalMiddle AgedAdultRecurrenceFollow-Up StudiesAgedTreatment OutcomeProspective StudiesProportional Hazards Models

Stichwörter der Autor:innen

cox regressionendoscopic surgical dilationidiopathic subglottic stenosis (iSGS)recurrenceserial intralesional steroid injections

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Department of Otolaryngology-Head & Neck Surgery, Western University, London, Ontario, Canada.
  • Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
  • Department of Otolaryngology-Head & Neck Surgery, Temerty Faculty of Medicine, University of Toronto, Unity Health Toronto-St. Michael's Hospital, Toronto, Ontario, Canada.
  • Department of Oncology, Western University, London, Ontario, Canada.
  • Department of Microbiology & Immunology, Western University, London, Ontario, Canada.
  • Department of Anatomy & Cell Biology, Western University, London, Ontario, Canada.

ORCID-Profile: Shengjie Ying, Jennifer Anderson, R Jun Lin

Förderung

  • American Laryngological Association
  • Academic Medical Organization of Southwestern Ontario
  • Department of Otolaryngology-Head and Neck Surgery at University of Toronto and Western University
  • Canadian Institute of Heath Research Canada Graduate Scholarship-Doctoral
  • Wolfe Surgical Research Professorship in the Biology of Head and Neck Cancers

Zitieren

APA

Ying, S., Zeng, P. Y. F., Fung, K., Khan, H., Cecchini, M. J., MacInnis, P., Anderson, J., Karimi, A. H., Al Jawhri, M., Pan, H., Le, N., Joris, K., Mymryk, J. S., Dumeaux, V., Barrett, J. W., Nichols, A. C., Lin, R. J., & Canadian Airways Research Group of the Canadian Society of Otolaryngology Collaborative Research Initiative (2025). Effect of Serial Intralesional Steroid Injections on Risk of Recurrence in Idiopathic Subglottic Stenosis. The Laryngoscope. https://doi.org/10.1002/lary.32179

Vancouver

Ying S, Zeng PYF, Fung K, Khan H, Cecchini MJ, MacInnis P, et al. Effect of Serial Intralesional Steroid Injections on Risk of Recurrence in Idiopathic Subglottic Stenosis. The Laryngoscope. 2025. doi:10.1002/lary.32179

BibTeX
@article{Ying2025,
  author = {Ying, Shengjie and Zeng, Peter Y F and Fung, Kevin and Khan, Halema and Cecchini, Matthew J and MacInnis, Patrick and Anderson, Jennifer and Karimi, Amir H and Al Jawhri, MohdWessam and Pan, Harrison and Le, Nhi and Joris, Krista and Mymryk, Joe S and Dumeaux, Vanessa and Barrett, John W and Nichols, Anthony C and Lin, R Jun and Canadian Airways Research Group of the Canadian Society of Otolaryngology Collaborative Research Initiative, Canadian Airways Research Group of the Canadian Society of Otolaryngology Collaborative Research Initiative},
  title = {Effect of Serial Intralesional Steroid Injections on Risk of Recurrence in Idiopathic Subglottic Stenosis},
  journal = {The Laryngoscope},
  year = {2025},
  doi = {10.1002/lary.32179}
}
Kostenlos starten →